Video from AACC: Cytovale immune-response test for sepsis

By Leo O'Connor, Editor in Chief
July 29, 2022

Cytovale CEO Ajay Shah discusses unmet needs in the sepsis testing market and the firm’s 10-minute direct-from-blood IntelliSep test.

The San Francisco-based startup has submitted an application to the U.S. Food and Drug Administration (FDA) for clearance of the system and test, which aims to help emergency departments to more effectively and quickly triage patients.

Click on the video below for the interview.

Shah AACC interview
Cytovale CEO Ajay Shah.

Cytovale to present new data on rapid sepsis test at AACC
Cytovale said Monday that it will present new data at AACC 2022 about its 10-minute IntelliSep test for sepsis and its associated system.
Bluejay Diagnostics completes clinical studies for sepsis triage
Bluejay Diagnostics on Wednesday announced the completion of clinical studies for its Symphony IL-6 Test for sepsis triage.
Nanomix launches trial of eLab analyzer and panel
Nanomix has launched a trial in Spain to evaluate its eLab mobile immunoassay diagnostic system and S1 Panel assay for the detection of critical infections.
Cytovale tests sepsis diagnostic in COVID-19 patients
Medical cell technology company Cytovale is set to conduct a pilot study of its rapid diagnostic test for sepsis in patients with suspected SARS-CoV-2...

Copyright © 2022

Last Updated lo 7/29/2022 10:09:33 AM